TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference
TELA Bio (NASDAQ: TELA), a medical technology company specializing in soft-tissue reconstruction solutions, has announced its participation in the upcoming Canaccord Genuity 45th Annual Growth Conference. The company's management team will deliver a presentation on August 13th, 2025, at 10:00 am ET. Investors and interested parties can access both the live presentation and archived webcast through the company's investor relations website at ir.telabio.com.
TELA Bio (NASDAQ: TELA), un'azienda di tecnologia medica specializzata in soluzioni per la ricostruzione dei tessuti molli, ha annunciato la sua partecipazione alla prossima Canaccord Genuity 45ª Conferenza Annuale sulla Crescita. Il team di gestione dell'azienda terrà una presentazione il 13 agosto 2025, alle 10:00 ET. Investitori e interessati potranno seguire la presentazione in diretta e rivedere la registrazione tramite il sito web delle relazioni con gli investitori all'indirizzo ir.telabio.com.
TELA Bio (NASDAQ: TELA), una empresa de tecnología médica especializada en soluciones para la reconstrucción de tejidos blandos, ha anunciado su participación en la próxima 45ª Conferencia Anual de Crecimiento de Canaccord Genuity. El equipo directivo de la empresa realizará una presentación el 13 de agosto de 2025 a las 10:00 am ET. Los inversores y partes interesadas podrán acceder a la presentación en vivo y a la retransmisión archivada a través del sitio web de relaciones con inversores de la compañía en ir.telabio.com.
TELA Bio (NASDAQ: TELA)는 연조직 재건 솔루션을 전문으로 하는 의료 기술 회사로, 다가오는 Canaccord Genuity 제45회 연례 성장 컨퍼런스에 참여할 예정임을 발표했습니다. 회사 경영진은 2025년 8월 13일 오전 10시(동부시간)에 발표를 진행할 예정입니다. 투자자 및 관심 있는 분들은 회사의 투자자 관계 웹사이트 ir.telabio.com을 통해 라이브 발표와 녹화된 웹캐스트를 시청할 수 있습니다.
TELA Bio (NASDAQ : TELA), une entreprise de technologie médicale spécialisée dans les solutions de reconstruction des tissus mous, a annoncé sa participation à la prochaine 45e conférence annuelle sur la croissance de Canaccord Genuity. L'équipe de direction de la société présentera le 13 août 2025 à 10h00 ET. Les investisseurs et parties intéressées pourront accéder à la présentation en direct ainsi qu'à la rediffusion via le site web des relations investisseurs de la société à l'adresse ir.telabio.com.
TELA Bio (NASDAQ: TELA), ein Medizintechnologieunternehmen, das sich auf Lösungen für die Weichgeweberekonstruktion spezialisiert hat, hat seine Teilnahme an der bevorstehenden 45. jährlichen Wachstums-Konferenz von Canaccord Genuity angekündigt. Das Managementteam des Unternehmens wird am 13. August 2025 um 10:00 Uhr ET eine Präsentation halten. Investoren und Interessierte können sowohl die Live-Präsentation als auch die archivierte Webcast über die Investor-Relations-Website des Unternehmens unter ir.telabio.com verfolgen.
- None.
- None.
MALVERN, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 45th Annual Growth Conference.
TELA’s management is scheduled to present at the Canaccord Genuity 45th Annual Growth Conference at 10:00 am ET on August 13th, 2025. Interested parties can access the live and archived webcast at ir.telabio.com.
About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Investor Contact
Louisa Smith
ir@telabio.com
FAQ
When is TELA Bio presenting at the Canaccord Genuity Growth Conference 2025?
How can investors access TELA Bio's Canaccord conference presentation?
What does TELA Bio (NASDAQ: TELA) specialize in?
Which conference is TELA Bio participating in during August 2025?
